Recommanded Product: 62-23-7. Recently I am researching about BIOLOGICAL EVALUATION; CATALYTIC INHIBITORS; N-PHENYLPYRROLAMIDES; GYRASE; OPTIMIZATION; DESIGN; POTENT; N-PHENYL-4,5-DIBROMOPYRROLAMIDES; KIBDELOMYCIN; DERIVATIVES, Saw an article supported by the Slovenian Research AgencySlovenian Research Agency – Slovenia [P1-0208]. Published in ACADEMIC PRESS INC ELSEVIER SCIENCE in SAN DIEGO ,Authors: Skok, Z; Durcik, M; Skledar, DG; Barancokova, M; Masic, LP; Tomasic, T; Zega, A; Kikelj, D; Zidar, N; Ilas, J. The CAS is 62-23-7. Through research, I have a further understanding and discovery of 4-Nitrobenzoic acid
Human DNA topoisomerase II is one of the major targets in anticancer therapy, however ATP-competitive inhibitors of this target have not yet reached their full potential. ATPase domain of human DNA topoisomerase II belongs to the GHKL ATPase superfamily and shares a very high 3D structural similarity with other superfamily members, including bacterial topoisomerases. In this work we report the discovery of a new chemotype of ATP-competitive inhibitors of human DNA topoisomerase II alpha that were discovered through screening of in-house library of ATP-competitive inhibitors of bacterial DNA gyrase and topoisomerase IV. Systematic screening of this library provided us with 20 hit compounds. 1,2,4-Substituted N-phenylpyrrolamides were selected for a further exploration which resulted in 13 new analogues, including 52 with potent activity in relaxation assay (IC50 = 3.2 mu M) and ATPase assay (IC50 = 0.43 mu M). Cytotoxic activity of all hits was determined in MCF-7 cancer cell line and the most potent compounds, 16 and 20, showed an IC50 value of 8.7 and 8.2 mu M, respectively.
About 4-Nitrobenzoic acid, If you have any questions, you can contact Skok, Z; Durcik, M; Skledar, DG; Barancokova, M; Masic, LP; Tomasic, T; Zega, A; Kikelj, D; Zidar, N; Ilas, J or concate me.. Recommanded Product: 62-23-7
Reference:
Phthalazine – Wikipedia,
,Phthalazine | C8H6N2 – PubChem